JP Morgan Out Negative On United Therapeutics, Says Near Term Deal Is Highly Unlikely; Is Referring to Evening Standard Report That Suggested GSK, Gilead, or Novartis Would Be Looking At A Possible Acquisition Of United Therapeutics
Paul Quintaro